COVID
Showing NaN - NaN of 6
Myeloproliferative Neoplasms (MPN) and COVID-19
Recruiting
- Myeloproliferative Neoplasm
- COVID
-
New York, New York
- +43 more
Apr 4, 2022
In-vitro Diagnostic Test to Predict COVID-19 Mortality and
Recruiting
- SARS-CoV 2
- +5 more
- CAG length <22
- CAG length >=22
-
Madrid, SpainHospital Universitario Ramon y Cajal
Feb 17, 2022
Pregnancy Related, COVID, Covid-19 Trial in Spain (Hydroxychloroquine, Placebo)
Completed
- Pregnancy Related
- +2 more
- Hydroxychloroquine
- Placebo
-
Segovia, Cartilla Y León, Spain
- +8 more
Jan 11, 2022
Adult and Neonatal/ Pediatric COVID-19 Patients in ECMO
Recruiting
- COVID
- +6 more
-
Innsbruck, Austria
- +96 more
Sep 3, 2021
COVID Trial in Getafe, Barakaldo, Madrid (Mesenchymal cells, Standard of care)
Withdrawn
- COVID
- Mesenchymal cells
- Standard of care
-
Getafe, Madrid, Spain
- +5 more
Aug 24, 2021
COVID, Respiratory Distress Syndrome Trial in Madrid (Allogeneic and expanded adipose tissue-derived mesenchymal stromal cells)
Suspended
- COVID
- Respiratory Distress Syndrome
- Allogeneic and expanded adipose tissue-derived mesenchymal stromal cells
-
Madrid, SpainFundacion Jimenez Diaz
Mar 15, 2021